The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SAE | -61.94% | -54.1% | -14.42% | +114% |
| S&P | +14.08% | +93.57% | +14.12% | +221% |
Shop Apotheke Europe NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. It operates under the DACH and International segments. The DACH segment includes medications and pharmacy-related BPC products sold to customers in Germany, Austria, and Switzerland. The International segment focuses on Belgium, the Netherlands, France, and Italy. The company was founded by Frank Köhler, Stephan Weber, and Marc Fischer in January 2001 and is headquartered in Sevenum, the Netherlands.
No news articles found for Redcare Pharmacy.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $719.23M | 25.2% |
| Gross Profit | $141.70M | 21.9% |
| Gross Margin | 19.70% | -0.5% |
| Market Cap | $1.50B | -42.2% |
| Market Cap / Employee | $0.66M | 0.0% |
| Employees | 2.3K | 9.2% |
| Net Income | -$7.34M | -3.3% |
| EBITDA | $15.06M | 47.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $150.37M | 51.3% |
| Accounts Receivable | $123.08M | 17.6% |
| Inventory | 171.2 | 20.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $304.13M | 29.6% |
| Short Term Debt | $88.27M | 881.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -3.14% | -0.8% |
| Return On Invested Capital | -7.26% | 0.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$35.59M | -236.3% |
| Operating Free Cash Flow | -$21.51M | -141.5% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 5.22 | 4.71 | 4.02 | 3.34 | -37.52% |
| Price to Sales | 1.12 | 0.96 | 0.71 | 0.53 | -54.39% |
| Price to Tangible Book Value | 28.94 | 26.10 | 28.56 | 34.35 | -15.87% |
| Price to Free Cash Flow TTM | 99.52 | 126.67 | 233.05 | 139.61 | 25.99% |
| Enterprise Value to EBITDA | -478.70 | 336.89 | 124.38 | 108.89 | -58.05% |
| Free Cash Flow Yield | 1.0% | 0.8% | 0.4% | 0.7% | -20.63% |
| Return on Equity | -9.6% | -9.8% | -7.5% | -7.0% | 46.48% |
| Total Debt | $278.24M | $246.82M | $445.30M | $392.40M | 61.00% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
